Viral Blip Dynamics during Highly Active Antiretroviral Therapy
Open Access
- 15 November 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (22), 12165-12172
- https://doi.org/10.1128/jvi.77.22.12165-12172.2003
Abstract
Although intermittent episodes of low-level viremia are often observed in well-suppressed highly active antiretroviral therapy (HAART)-treated patients, the timing and amplitude of viral blips have never been examined in detail. We analyze here the dynamics of viral blips, i.e., plasma VL measurements of >50 copies/ml, in 123 HAART-treated patients monitored for a mean of 2.6 years (range, 5 months to 5.3 years). The mean (± the standard deviation) blip frequency was 0.09 ± 0.11/sample, with about one-third of patients showing no viral blips. The mean viral blip amplitude was 158 ± 132 human immunodeficiency virus type 1 (HIV-1) RNA copies/ml. Analysis of the blip frequency and amplitude distributions suggest that two blips less than 22 days apart have a significant chance of being part of the same episode of viremia. The data are consistent with a hypothetical model in which each episode of viremia consists of a phase of VL rise, followed by two-phase exponential decay. Thus, the term “viral blip” may be a misnomer, since viral replication appears to be occurring over an extended period. Neither the frequency nor the amplitude of viral blips increases with longer periods of observation, but the frequency is inversely correlated with the CD4 + -T-cell count at the start of therapy, suggesting that host-specific factors but not treatment fatigue are determinants of blip frequency.Keywords
This publication has 23 references indexed in Scilit:
- The Distribution of Viral Blips Observed in HIV-1 Infected Patients Treated with Combination Antiretroviral TherapyBulletin of Mathematical Biology, 2003
- Modeling the Effects of Vaccination on Chronically Infected HIV-Positive PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Prevalence and clinical correlates of HIV viremia (`blips') in patients with previous suppression below the limits of quantificationAIDS, 2002
- Transient Relapses (“Blips”) of Plasma HIV RNA Levels During HAART Are Associated With Drug ResistanceJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Transient Relapses (“Blips”) of Plasma HIV RNA Levels During HAART Are Associated With Drug ResistanceJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination TherapyJAMA, 2001
- Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral TherapyJAMA, 1999
- Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral TherapyNew England Journal of Medicine, 1999
- Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral TherapyNew England Journal of Medicine, 1999
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997